Don't panic here. Remember that this stock had 20M shares short. Everyone is surprised at this FDA announcement that came in like a thief in the night. Look at the volume today and price is down. Shorts are moving on this and all you have to do is be patient. Approval means revenue, interest from bigger investors, and market cap of well over 700-800M to maybe even over 1B once sales ramp up. Only a matter of time. Remain calm, you did the right thing in buying into this company.
I just bought 1000 shares myself. Shocked to see so many sell just after approval, but so much for common sense. Of course it is not a blockbuster cancer 'drug' but definitely will be very profitable, w/o the usual cost of having to detail too much of (explaining) a new drug, except to docs (the test)....imo. Very good margins. Maybe buy shares now, and more later if the impatient holders just can't wait....lol.
This same #$%$ happened to ALEXA with their FDA approval for Staccato delivery method. What a minipulated market-IMO, should be a $6 stock or better, based on what analyst have indicated.
Sentiment: Strong Buy
Me three.. I bought some in their first fda play and lost when fda declined. Now I pumped up some more in their next play hoping that I could recapture my lost money....and what do I find - Empty coffers :( . One thing I must learn, never invest in an FDA play when its quite certain that approval is coming their way.